Buscar
IO Biotech Inc
IOBTAñadir a la lista de seguimiento
0.048USD
0.0000.00%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
366.94KCap. mercado
PérdidaP/E TTM
Más Datos de IO Biotech Inc Compañía
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The Company develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The Company is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.
Información de IO Biotech Inc
Símbolo de cotizaciónIOBT
Nombre de la empresaIO Biotech Inc
Fecha de salida a bolsaNov 05, 2021
Director ejecutivoZocca (Mai-Britt)
Número de empleados80
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 05
DirecciónOle Maaloes Veh 3
CiudadCOPENHAGEN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísDenmark
Código postal2200
Teléfono4570702980
Sitio Webhttps://www.iobiotech.com/
Símbolo de cotizaciónIOBT
Fecha de salida a bolsaNov 05, 2021
Director ejecutivoZocca (Mai-Britt)
Ejecutivos de IO Biotech Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Mai-Britt Zocca, Ph.D.
Dr. Mai-Britt Zocca, Ph.D.
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
76.47K
--
Mr. Devin Whittemore Smith
Mr. Devin Whittemore Smith
General Counsel, Company Secretary
General Counsel, Company Secretary
16.93K
+70.87%
Ms. Heidi Hunter
Ms. Heidi Hunter
Independent Director
Independent Director
15.00K
--
Dr. Peter Hirth, Ph.D.
Dr. Peter Hirth, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Christian E. Elling, Ph.D.
Dr. Christian E. Elling, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kathleen Sereda Glaub
Ms. Kathleen Sereda Glaub
Independent Director
Independent Director
--
--
Mr. David V. Smith
Mr. David V. Smith
Independent Director
Independent Director
--
--
Mr. Brian Burkavage
Mr. Brian Burkavage
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
--
--
Ms. Amy B. Sullivan
Ms. Amy B. Sullivan
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
--
--
Dr. Qasim Ahmad, M.D.
Dr. Qasim Ahmad, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Mai-Britt Zocca, Ph.D.
Dr. Mai-Britt Zocca, Ph.D.
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
76.47K
--
Mr. Devin Whittemore Smith
Mr. Devin Whittemore Smith
General Counsel, Company Secretary
General Counsel, Company Secretary
16.93K
+70.87%
Ms. Heidi Hunter
Ms. Heidi Hunter
Independent Director
Independent Director
15.00K
--
Dr. Peter Hirth, Ph.D.
Dr. Peter Hirth, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Christian E. Elling, Ph.D.
Dr. Christian E. Elling, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kathleen Sereda Glaub
Ms. Kathleen Sereda Glaub
Independent Director
Independent Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de IO Biotech Inc?
Los cinco principales accionistas de IO Biotech Inc son: Dr. Mai-Britt Zocca, Ph.D.
¿Cuántas instituciones poseen acciones de IO Biotech Inc (IOBT)?
A fecha de 2026Q1, 56 instituciones poseen acciones de IO Biotech Inc, con un valor de mercado combinado de aproximadamente 33.96M, lo que representa el 47.71% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -19145442.00.